Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response

• Philippa C. Matthews ,

  * E-mail: philippa.matthews@crick.ac.uk

  Affiliations The Francis Crick Institute, London, United Kingdom, Division of Infection and Immunity, University College London, London, United Kingdom, Department of Infectious Diseases, University College London Hospitals, London, United Kingdom

  https://orcid.org/0000-0002-4036-4269

  ⨯
• Tongai Maponga,

  Affiliation Division of Virology, Tygerberg Hospital, University of Stellenbosch, Stellenbosch, South Africa

  ⨯
• Indrajit Ghosh,

  Affiliations Mortimer Market Centre, Central North West London NHS Foundation Trust, London, United Kingdom, Find & Treat, Inclusion Health, University College London, London, United Kingdom

  ⨯
• Maud Lemoine,

  Affiliation Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology, Imperial College London, London, United Kingdom

  ⨯
• Ponsiano Ocama,

  Affiliation Makerere University College of Health Sciences, Kampala, Uganda

  ⨯
• Ibrahim Abubakar,

  Affiliation Faculty of Population Health Sciences, University College London, Mortimer Market Centre, London, United Kingdom

  ⨯
• Alistair Story,

  Affiliation Find & Treat, Inclusion Health, University College London, London, United Kingdom

  ⨯
• Stuart Flanagan

  Affiliations Department of Infectious Diseases, University College London Hospitals, London, United Kingdom, Mortimer Market Centre, Central North West London NHS Foundation Trust, London, United Kingdom

  ⨯